Lecanemab in Early Alzheimer’s Disease
Author:
Publisher
Massachusetts Medical Society
Subject
General Medicine
Link
http://www.nejm.org/doi/pdf/10.1056/NEJMc2301380
Reference7 articles.
1. Lecanemab in Early Alzheimer’s Disease
2. Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
3. Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
4. Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
5. Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The higher benefit of lecanemab in males compared to females in CLARITY AD is probably due to a real sex effect;2024-07-12
2. From Lab Bench to Hope: Emerging Gene Therapies in Clinical Trials for Alzheimer’s Disease;Molecular Neurobiology;2024-07-03
3. Fosgonimeton attenuates amyloid-beta toxicity in preclinical models of Alzheimer's disease;Neurotherapeutics;2024-07
4. Highly sensitive in-situ growth gold dendrite structure electrochemical sensor for early Alzheimer's disease screening;Chemical Engineering Journal;2024-06
5. Identification of isoaspartate-modified transthyretin as potential target for selective immunotherapy of transthyretin amyloidosis;Amyloid;2024-05-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3